American Society of Hematology logo

PlatformQ Health to Present Poster at 2019 ASH Annual Meeting

PlatformQ Health will present a poster session at the 2019 ASH Annual Meeting sharing insights from recent CME and patient education activities on Follicular Lymphoma December 8, 2019. In addition, the abstract will be included in their Blood journal as supplement. The patient and clinician video-based activities were developed in collaboration with The Leukemia and […]

Read More

Carcinoid Cancer Foundation program Neuroendocrine tumor

New Education for People Who Have Neuroendocrine Tumors

Following two successful programs, produced in partnership with the Carcinoid Cancer Foundation, PlatformQ Health is pleased to announce an all-new program for patients and caregivers on Neuroendocrine Tumors that will premiere live at 1pm ET on August 14, 2019 on CancerCoachLive. The two previous programs focused specifically on carcinoid syndrome, a condition that effects a […]

Read More

Ovarian Cancer CME

Overview of Ovarian Cancer: New CME

Join us on December 20, 2018 at 1pm ET for live CME about ovarian cancer, worth 1.0 AMA PRA Category 1 Credit™.   According to the CDC, ovarian cancer is the second most common gynecologic cancer, comprising 3% of all cancers in women. Approximately 11 out of every 100,000 women are diagnosed with new cases annually (over […]

Read More

Follicular Lymphoma CME Patient Education

Overview of Follicular Lymphoma: New CME

A new follicular lymphoma CME program worth 1 AMA PRA Category 1 Credits™, is now available on demand. Find it here.  In the Western hemisphere, follicular lymphoma (FL) is the most common non-Hodgkin lymphoma (NHL). In the US in 2018, it is expected that approximately 74,680 new cases of NHL will be diagnosed and 20% […]

Read More

Follicular Lymphoma Patient Education

Managing Your Cancer as a Chronic Disease

Current statistics estimate that this year, of the 1,735,350 new cases of cancer that will be diagnosed in the United States, over 1.1 million people will face the challenges of continuing to live a meaningful life with cancer. While everyone has heard about the rigors of and side effects than can accompany cancer treatments such […]

Read More

ASCO 2019 floorplan

PlatformQ Health & OMedLive at ASCO 2018

OMedLive, an online oncology learning channel from PlatformQ Health Education, will be in Chicago for the ASCO Annual Meeting from June 1-5. Our commitment to oncology practice and cancer care makes ASCO 2018 one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes […]

Read More

AUA 2018

AUA 2018 Full of New Research, Processes, and Inventions

Jeff Arnold, General Manager at PlatformQ Health, attended the latest meeting of the American Urological Association (AUA) in San Francisco. Arnold, who joined the PQH team earlier this year, was a natural choice to represent our team at the AUA 2018 meeting as he focuses on leveraging our platform to deliver outcomes-driven education in Urology, […]

Read More

Prostate Cancer CME

Ground-Breaking PRECISION Study Results: MRI Superior for Prostate Cancer

Currently, the guidelines around prostate cancer for physicians like me follow are murky, and best practices are subject to debate by different medical organizations. A widely-known recommendation called a PSA (Prostate Specific Antigen) screening, for example, has been fraught with failings and blamed for causing an unacceptable number of unnecessary prostate biopsies. On March 19, […]

Read More

NHL Patient Educational Outcomes

Online Patient Education Drives Meaningful Outcomes

The inaugural program for CancerCoachLive, PlatformQ Health’s educational channel for online patient education about different forms of cancer, was launched in 2016 through a partnership with The Leukemia & Lymphoma Society (LLS) focusing on educating patients with B-cell non-Hodgkin lymphomas (NHL).  Building on LLS’s goal to empower patients through education, this program aimed to improve knowledge […]

Read More

Acute Myeloid Leukemia (AML) Patient Education

A Review of Acute Myeloid Leukemia (AML)

Acute myelogenous/myeloid leukemia (AML) is one of the malignant diseases of the bone marrow. In this disease, hematopoietic precursor cells become arrested in early stages of development. Typically, AML is distinguished from other blood disorders by the presence of greater than 20% blasts seen in the bone marrow.  AML has many names including acute myelocytic […]

Read More

rare disease zebra

Rare Diseases: Why We All Need to be Aware

While rare diseases are uncommon, there are a multitude of them. In the US, there are approximately 7,000 diseases that are considered to be rare. It is approximated that there are nearly 300,000,000 patients around the world who are diagnosed with a rare disease. In the US, a rare disease is defined as any disease […]

Read More

Prepare for doctor appointment

Colorectal Cancer Around the Globe

Colorectal cancer is one of the most common cancers in the US, as well as around the world. Additionally, it remains one of the leading causes of cancer deaths as well. Our knowledge of this deadly disease increased exponentially in recent years and we now have screening tests and a plethora of treatment modalities. Yet, […]

Read More

PlatformQ Health CME

Cases, Challenges, and Controversies on High-Risk Pediatric Neuroblastoma

This OMEDLIVE presentation is Part Two of a two-part series surrounding Pediatric Neuroblastoma. During the conversation, Dr. Jason Shohet and Jennifer Saggio, MSN, CRNP, CPON focus on the following areas: Overview of pathology and standard therapy for high-risk NB Required imaging and evaluations for the revised INRGSS system Overall treatment scheme, including recent proposed changes […]

Read More

lung

The Genetics of Lung Cancer

Everyone is aware of the link between cigarette smoking and lung cancer. However, recent research is showing strong genetic contributors to the development of these cancers. Even among smokers, genetics appear to play some role. Not every smoker develops lung cancer and not everyone who develops lung cancer smokes. Here, we’ll review the genetics of […]

Read More

global

GASTRIC CANCER: A GLOBAL VIEW

Gastric cancer, also known as stomach cancer, remains an aggressive cancer around the globe. Over the past several decades, there has been a slight decrease in incidence, yet it remains the fourth most common cancer and the second deadliest across the world.  Some factors that are thought to be responsible for the declining incidence include […]

Read More

patient and doctor

Breast Cancer in Men: Where we are in 2016

While everyone is aware that breast cancer in woman exists, many do not know men can be similarly afflicted. Breast cancer in women has its own awareness month (October) and its own symbol of awareness, the pink ribbon. Breast cancer in men, on the other hand, do not even have treatments tailored to them but […]

Read More

World Cancer Day 2016

Our First CME World Cancer Day Challenge

  When did learning give back so much? From today through February 10th, join our World Cancer Day Challenge to earn CME and help us donate to cancer research at the same time! For every OMedLive session you attend, we’ll donate $10 to the American Cancer Society. For every CME credit hour claimed, we’ll boost […]

Read More

blood

Nursing Perspectives for Optimizing Hemophilia Treatment

In this OMedLive video, nurses Brenda Riske and Regina B. Butler discuss “optimizing outcomes in hemophilia treatment” from a nurse’s perspective. Hemophilia, a genetic bleeding disease, affects about 20,000 Americans and over 400,000 people worldwide. A rare and serious condition, it requires a vigilant medical team for optimal patient care. Brenda Riske, RN, MSN, MBA, […]

Read More

pancreatic cancer in body

Optimal Treatments for Patients with Metastatic Pancreatic Cancer (MPCA)

In this continuing medical education video session, Dr. Tanios Bekaii-Saab tells us, “in the last 30 years, overall five-year relative survival rates increased for most cancers except for lung and pancreatic cancers, which have shown the least improvement.” Dr. Bekaii-Saab, MD, FACP from the Ohio State University James Cancer Hospital takes us through current modes […]

Read More